Bid Banana
PricingBid helpAPILog inStart free trial
Log inStart free trial

Before you respond

  • Federal grantsHow to Find Grants for Nonprofits
  • Healthcare RFPsHealthcare and Medical Services Bids and Bidding Guide
  • How to apply for a grantGrant Applications vs. RFPs: Writing Differences Explained
More healthcare and medical services bids →Must-win bid? Bring in The Bid Lab →
Bid Banana
SearchPricingBid helpBrowse bidsAPISupportFAQPrivacy PolicyTerms of UseAI Use Policy

This website and its content is copyright of The Bid Lab © 2026. The Bid Lab is a trademark of Bid Lab, LLC. All rights reserved.

  1. Bid Banana
  2. ›Bids
  3. ›Federal
  4. ›Cutting-Edge Basic Research Awards (CEBRA) (R21 Clinical…

U.S. National Institutes of Health·United States of America

Cutting-Edge Basic Research Awards (CEBRA) (R21 Clinical Trial Optional)

Closes 8/11/2027$100k – $150kGrants Notice
Get bids like this by emailBid source

Description

The National Institute on Drug Abuse (NIDA) Cutting-Edge Basic Research Award (CEBRA) is designed to foster highly innovative or conceptually creative research related to the etiology, pathophysiology, prevention, or treatment of substance use disorders (SUDs). The proposed research should develop, and/or adapt, revolutionary techniques or methods for addiction research or that show promising future applicability to SUD research, and/or test an innovative and significant hypothesis for which there are scant precedent or preliminary data and which, if confirmed, would transform current thinking. Key aspects of this opportunity include: • Support for high-risk and potentially high-impact research that is underrepresented or not included in NIDA's current portfolio • Emphasis on transforming SUD research through innovative techniques, methods, or hypotheses • Eligibility for various types of organizations, including state and local governments, nonprofits, and for-profit businesses • Availability of funding for up to 2 years, with an estimated total award amount of $150,000

Attached files

Contact

[email protected]

(301) 402-2541

Key dates

Opened
12/30/2024
Closes
8/11/2027

Last updated

Details

Type
Grants Notice
Industry
Healthcare and Medical Services
NAICS
541710
Solicitation №
PAR-25-101

Budget estimate

$100,000 – $150,000

The estimated budget for this opportunity is up to $150,000, as specified in the document. This amount is likely to be the total award for the entire project duration, which is estimated to be 2 years. The actual budget may vary depending on the specific research proposal and the agency's funding decisions. Factors that may influence the likely payment range include the complexity of the research, the number of personnel involved, and the equipment or resources required.

AI estimate from the solicitation

Similar opportunities

Matched by Bid Banana AI™

Bid Banana · 1.6M+ bids and awards 🍌

You found this one. Bid Banana has 1.6M+ bids and awards.

You found this bid by looking. Bid Banana searches open government bids across all 50 states, updated daily, so you stop hunting: save a search once and we email you your new matches, daily or weekly.

1.6M+
bids & awards
All 50
states
4,000+
agencies
Start your 7-day free trial

Plans from $49.99/month. Cancel anytime, no setup fees.

Built by The Bid Lab, answering RFPs since 2017.

U.S. National Institutes of Health·United States of America

Top match · 86%

NIDA Avenir Program: Fundamental Mechanistic Research in Addiction Science

Closes 5/25/2027Opened 9/10/2026

U.S. National Institutes of Health·United States of America

85% match

NIDA Mentored Clinical Scientist Development Program Award in Substance Use and Substance Use Disorder Research (K12 Clinical Trial Optional)

Closes 11/13/2026Opened 1/3/2024

U.S. National Institutes of Health·United States of America

84% match

Specialized Alcohol Research Centers (P50 Clinical trial Optional)

Closes 1/27/2027Opened 1/30/2026

U.S. National Institutes of Health·United States of America

84% match

Exploratory Clinical Neuroscience Research on Substance Use Disorders (R61/R33 Clinical Trial Optional)

Closes 6/16/2028Opened 3/16/2026

U.S. National Institutes of Health·United States of America

83% match

Development of Interventions to Prevent and Treat Substance Use Disorders and Overdose (UG3/UH3 - Clinical Trial Optional)

Closes 8/21/2028Opened 5/13/2025

U.S. National Institutes of Health·United States of America

83% match

NIH Director's Transformative Research Award (R01 Clinical Trial Optional)

Closes 9/2/2027Opened 9/3/2026

U.S. National Institutes of Health·United States of America

82% match

Limited Competition: Centers of Biomedical Research Excellence: Development Phase (COBRE-D) (P30 - Clinical Trial Not Allowed)

Closes 5/26/2029Opened 9/17/2025

U.S. National Institutes of Health·United States of America

82% match

NIDCD Early Career Research(ECR) Award (R21 Clinical Trial Optional)

Closes 10/15/2027Opened 2/27/2024

U.S. National Institutes of Health·United States of America

82% match

Pilot and Feasibility Studies in Preparation for Substance Use and HIV Prevention Intervention and Services Research Trials (R34 Clinical Trial Optional)

Closes 7/16/2029Opened 1/26/2026

U.S. National Institutes of Health·United States of America

82% match

Development of Models, New Approach Methodologies, and Biological Materials for Studying Human Health and Diseases (R21 Clinical Trial Not Allowed)

Closes 2/15/2028Opened 9/16/2026

U.S. National Institutes of Health·United States of America

81% match

Accelerating the Pace of Substance Use Research Using Existing Data (R21 Clinical Trial Not Allowed)

Closes 12/3/2027Opened 12/5/2024

U.S. National Institutes of Health·United States of America

81% match

Maximizing Investigators' Research Award (MIRA) (R35 - Clinical Trial Optional)

Closes 5/26/2028Opened 6/30/2025

U.S. National Institutes of Health·United States of America

81% match

High Priority HIV and Substance Use Research (R01 Clinical Trial Optional)

Closes 3/6/2027Opened 8/2/2024

U.S. National Institutes of Health·United States of America

81% match

Limited Competition: John Lewis NIMHD Research Endowment Program (S21 Clinical Trial Not Allowed)

Closes 5/24/2027Opened 9/8/2026

U.S. National Institutes of Health·United States of America

81% match

Bioengineering Research Grants (BRG) (R01 Clinical Trial Optional)

Closes 7/5/2029Opened 9/9/2025

U.S. National Institutes of Health·United States of America

81% match

Collaborative Initiative on Fetal Alcohol Spectrum Disorders (CIFASD), Research Program (U19 Clinical Trial Optional)

Closes 9/24/2027Opened 10/6/2026

U.S. National Institutes of Health·United States of America

81% match

Avant Garde/Avenir Awards for Investigators Conducting High Risk/High Reward Research on HIV and Substance Use (or Substance Use Disorders) (DP1 Clinical Trial Optional)

Closes 9/25/2028Opened 5/28/2025

U.S. National Institutes of Health·United States of America

81% match

Limited Competition: Ruth L. Kirschstein National Research Service Award (NRSA) Postdoctoral Research Training Grant for the Clinical and Translational Science Awards (CTSA) Program (T32 Clinical Trial Not Allowed)

Closes 9/28/2027Opened 12/12/2024

U.S. National Institutes of Health·United States of America

81% match

NIH Exploratory/Developmental Research Project Grant (Parent R21 Clinical Trial Required)

Closes 1/7/2028Opened 12/18/2024

U.S. National Institutes of Health·United States of America

81% match

Support for Research Excellence (SuRE) Award (R16 Clinical Trial Not Allowed)

Closes 9/7/2028Opened 5/7/2025

U.S. National Institutes of Health·United States of America

81% match

Academic Research Enhancement Award (AREA) for Undergraduate-Focused Institutions (R15 Clinical Trial Not Allowed)

Closes 1/7/2028Opened 5/8/2024

U.S. National Institutes of Health·United States of America

81% match

NIH Exploratory/Developmental Research Project Grant (Parent R21 Clinical Trial Not Allowed)

Closes 1/7/2028Opened 12/18/2024

U.S. National Institutes of Health·United States of America

80% match

BRAIN Initiative: Research Opportunities Using Invasive Neural Recording and Stimulating Technologies in the Human Brain (R01 Clinical Trial Not Allowed)

Closes 2/8/2029Opened 8/28/2025

U.S. National Institutes of Health·United States of America

80% match

Ruth L. Kirschstein National Research Service Award (NRSA) Institutional Research Training Grant (Parent T32)

Closes 5/4/2028Opened 1/26/2023

U.S. National Institutes of Health·United States of America

80% match

HEAL Initiative: Translating Addiction Epidemiology, Prevention, Treatment, and Recovery Research into Practice (R61/R33 - Clinical Trial Optional)

Closes 2/9/2029Opened 6/4/2026